Hutchmed completes rolling submission of NDA to USFDA for fruquintinib
NDA supported by data from global Phase III FRESCO-2 study in the U.S., Europe, Japan and Australia along with data from Phase III FRESCO study conducted in China
NDA supported by data from global Phase III FRESCO-2 study in the U.S., Europe, Japan and Australia along with data from Phase III FRESCO study conducted in China
Abbas will closely partner with CBC's business teams to identify, assess, and pursue investment opportunities and strategic acquisitions
Getinge has a strong market share in India within several product segments
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, (RLD Rexulti) had estimated annual sales of US $1,575 million in the US (IQVIA MAT December 2022)
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
Subscribe To Our Newsletter & Stay Updated